Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Putter

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 8, 2013
The DULK (Dutch leakage) and modified DULK score compared: actively seek the leakM den Dulk, M J Witvliet, K Kortram, et al.
European Radiology|March 17, 2015
No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CTJudith Kooiman, Wilke R van de Peppel, Yvo W J Sijpkens, et al.
The British Journal of Surgery|November 24, 2012
Expression of cell adhesion molecules and prognosis in breast cancerS Saadatmand, E M de Kruijf, A Sajet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trialJ G H van Nes, C Seynaeve, E Maartense, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 24, 2014
Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancerA Charehbili, M N Wasser, V T H B M Smit, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 13, 2019
Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosisR C Melchers, R Willemze, M W Bekkenk, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 13, 2020
Using a quality of life (QoL)-monitor: preliminary results of a randomized trial in Dutch patients with early breast cancerR T Lugtenberg, M J Fischer, F de Jongh, et al.
Gynecologic Oncology|March 15, 2022
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)C C B Post, A M Westermann, I A Boere, et al.
British Journal of Cancer|May 3, 2014
Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancerI J Goossens-Beumer, E C M Zeestraten, A Benard, et al.
Breast Cancer Research and Treatment|March 29, 2012
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side studyJ G H van Nes, D B Y Fontein, E T M Hille, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 8, 2013
The DULK (Dutch leakage) and modified DULK score compared: actively seek the leakM den Dulk, M J Witvliet, K Kortram, et al.
European Radiology|March 17, 2015
No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CTJudith Kooiman, Wilke R van de Peppel, Yvo W J Sijpkens, et al.
The British Journal of Surgery|November 24, 2012
Expression of cell adhesion molecules and prognosis in breast cancerS Saadatmand, E M de Kruijf, A Sajet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trialJ G H van Nes, C Seynaeve, E Maartense, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 24, 2014
Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancerA Charehbili, M N Wasser, V T H B M Smit, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 13, 2019
Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosisR C Melchers, R Willemze, M W Bekkenk, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 13, 2020
Using a quality of life (QoL)-monitor: preliminary results of a randomized trial in Dutch patients with early breast cancerR T Lugtenberg, M J Fischer, F de Jongh, et al.
Gynecologic Oncology|March 15, 2022
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)C C B Post, A M Westermann, I A Boere, et al.
British Journal of Cancer|May 3, 2014
Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancerI J Goossens-Beumer, E C M Zeestraten, A Benard, et al.
Breast Cancer Research and Treatment|March 29, 2012
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side studyJ G H van Nes, D B Y Fontein, E T M Hille, et al.
Pageof 16